Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus.
about
Brain monoglyceride lipase participating in endocannabinoid inactivationThe endocannabinoid system as an emerging target of pharmacotherapyGlutamatergic substrates of drug addiction and alcoholismThe orphan receptor GPR55 is a novel cannabinoid receptorMarijuana and cannabinoid regulation of brain reward circuitsNoladin ether, a putative endocannabinoid, attenuates sensory neurotransmission in the rat isolated mesenteric arterial bed via a non-CB1/CB2 G(i/o) linked receptorCannabinoid activation of PPAR alpha; a novel neuroprotective mechanismNovel cannabinoid receptorsExcess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agentsCannabinoids and psychosisControl of cannabinoid CB1 receptor function on glutamate axon terminals by endogenous adenosine acting at A1 receptorsThe endogenous cannabinoid system and drug addiction: 20 years after the discovery of the CB1 receptorInternational Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂Cannabinoids attenuate norepinephrine-induced melatonin biosynthesis in the rat pineal gland by reducing arylalkylamine N-acetyltransferase activity without involvement of cannabinoid receptorsCoactivation of pre- and postsynaptic signaling mechanisms determines cell-specific spike-timing-dependent plasticity.Neuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity.Cannabinoid CB1 receptor immunoreactivity in the prefrontal cortex: Comparison of schizophrenia and major depressive disorder.Statistical Parametric Mapping reveals ligand and region-specific activation of G-proteins by CB1 receptors and non-CB1 sites in the 3D reconstructed mouse brain.Delirium and High Creatine Kinase and Myoglobin Levels Related to Synthetic Cannabinoid WithdrawalMinireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55.Anandamide potentiation of miniature spontaneous excitatory synaptic transmission is mediated via IP3 pathway.In vivo pharmacology of endocannabinoids and their metabolic inhibitors: therapeutic implications in Parkinson's disease and abuse liabilityNeuroprotective therapies after perinatal hypoxic-ischemic brain injury.Are CB(1) Receptor Antagonists Nootropic or Cognitive Impairing Agents?Modulation of NMDA and AMPA-mediated synaptic transmission by CB1 receptors in frontal cortical pyramidal cells.Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophreniaDynamic changes of CB1-receptor expression in hippocampi of epileptic mice and humans.Redistribution of CB1 cannabinoid receptors in the acute and chronic phases of pilocarpine-induced epilepsyPotential antipsychotic properties of central cannabinoid (CB1) receptor antagonists.Cross-substitution of Δ9-tetrahydrocannabinol and JWH-018 in drug discrimination in rats.Cannabidiol: an overview of some pharmacological aspects.Cannabis and the brain.Species and strain differences in the expression of a novel glutamate-modulating cannabinoid receptor in the rodent hippocampus.Regulation of IPSP theta rhythm by muscarinic receptors and endocannabinoids in hippocampus.Baths salts, spice, and related designer drugs: the science behind the headlines.Cannabinoids inhibit excitatory inputs to neurons in the shell of the nucleus accumbens: an in vivo electrophysiological study.Control of spasticity in a multiple sclerosis model is mediated by CB1, not CB2, cannabinoid receptors.Endocannabinoids and neuroprotection.Endocannabinoid signaling in midbrain dopamine neurons: more than physiology?The therapeutic potential of the cannabinoids in neuroprotection.
P2860
Q24533828-8232718E-C51D-4729-9CB9-DC5BABAD0771Q24648473-9CF0597D-1B4A-4F13-90D7-DF92B7557351Q24648924-7CD763E5-AD8E-4531-B152-E4FD420A1412Q24670137-36263863-83C3-42B2-AFCA-DC78D1EF37DCQ24671514-8AA16900-AF34-49E2-9658-D107CD167238Q24671838-D94801D8-9B2C-48A1-9C3E-56DE6EE911EDQ24681426-3B934C4C-9033-4164-8AF1-A0438D5030E1Q24681482-9905AB09-4C5F-4212-B733-7CC0676C857FQ28075692-C50A206C-FEA4-4E57-9745-ABED3C785EF4Q28241328-71C23820-8D59-4751-B987-73BAB1A81C15Q28270337-78CA1250-C4EF-41A7-B483-2D82BDCBB1BEQ28280255-919CECFF-FA23-4E8C-B952-2EC271ADCBF1Q28298445-A061300E-A000-475C-B827-52D202CBFC59Q28574512-B1155480-D44A-4FA5-BB7E-B535C5F0F392Q30480909-C01003C3-F74F-4528-B54F-A552792343CFQ30493991-502767EA-279B-486A-925C-74E59F969419Q30497212-D0EF3167-BC7F-492D-A36A-E11359C4470FQ30497569-1C9A2D2F-65CB-4C9E-9CF7-D9E46607C798Q33594167-4E6198D8-4DB0-475C-93DD-FEEE1B36CAB6Q33636763-58F67457-39E9-4EA9-9118-A7A02D902704Q33699215-F24A7DEB-270E-4BA2-BD14-443A241633FBQ33751118-1BAA4774-9DB8-422B-BF4C-628C6374FA30Q33772042-8F299F86-9B18-43AA-8C9D-19D7AFC65D26Q33901801-CF92C357-161F-413B-82DB-9B3B7BFB22F0Q33923685-9C4FBD1C-5615-4459-97B3-3314861E115DQ33932087-1BFFA3DD-1F2F-4BEE-A70E-A75BF46100FFQ34015797-EE2718E7-F96C-4DED-BEA1-C846EBB2CA2FQ34072654-0A75B574-E649-4CAA-84D3-94145400C6C7Q34103173-AF5EED54-3693-4F30-A28B-9697967640C0Q34115633-582FEBAE-079D-452B-BDBD-B17B72DF6134Q34157378-FC38DC15-2284-4AAD-AF42-D2EA59751FD2Q34199483-F468638A-27F8-4BCC-A538-18E2400C9942Q34312878-063DB888-29DC-40C4-8464-B90B02460CEDQ34441980-FAE72A82-DD9F-42DD-8497-5AD80CCDC0C6Q34491601-A8E8BF55-172F-4964-B37B-D13828B4F123Q34524477-9DC571A4-C35A-45CF-B697-54DA6AB463BCQ34574015-06700772-303D-4A76-97DA-D1E0078390CCQ34611968-FE95FDE8-100A-47B2-9321-6BFE80B928A5Q34967151-66200291-7DF5-4337-9C29-CD0BB0425A2FQ34974856-FAB86994-B6BB-4C89-99EF-CCD2E9F9F1D6
P2860
Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Novel cannabinoid-sensitive re ...... ansmission in the hippocampus.
@en
Novel cannabinoid-sensitive re ...... ansmission in the hippocampus.
@nl
type
label
Novel cannabinoid-sensitive re ...... ansmission in the hippocampus.
@en
Novel cannabinoid-sensitive re ...... ansmission in the hippocampus.
@nl
prefLabel
Novel cannabinoid-sensitive re ...... ansmission in the hippocampus.
@en
Novel cannabinoid-sensitive re ...... ansmission in the hippocampus.
@nl
P921
P1433
P1476
Novel cannabinoid-sensitive re ...... ransmission in the hippocampus
@en
P2093
P356
10.1016/S0306-4522(01)00287-1
P407
P577
2001-01-01T00:00:00Z